Empiricotx

1 known investors

Empirico discovers and develops siRNA medicines designed to mimic naturally-occurring genetic variants that have beneficial effects on health and disease. Using its human genetics and siRNA chemistry platforms, the company advances a pipeline of clinical and preclinical precision medicine programs targeting common diseases with unmet need.